Clinical Research Directory
Browse clinical research sites, groups, and studies.
PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
Sponsor: Sunnybrook Health Sciences Centre
Summary
This is a phase III, multi-centre, double blind, randomized controlled trial of patients with traumatic brain injury (TBI).
Official title: PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1100
Start Date
2018-07-19
Completion Date
2027-12
Last Updated
2024-09-19
Healthy Volunteers
No
Conditions
Interventions
Dalteparin
Dalteparin in prophylactic doses administered daily if screening criteria are satisfied.
Saline
Saline in prophylactic doses administered daily if screening criteria are satisfied.
Locations (12)
Foothills Medical Centre
Calgary, Alberta, Canada
Royal Alexandra Hospital
Edmonton, Alberta, Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada
Hamilton Health Sciences Centre
Hamilton, Ontario, Canada
Kingston General Hospital
Kingston, Ontario, Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
Sunnybrook Health Science Centre
Toronto, Ontario, Canada
Unity Health Toronto
Toronto, Ontario, Canada
Hopital de L'Enfant-Jesus
Québec, Quebec, Canada
Royal University Hospital
Saskatoon, Saskatchewan, Canada